Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.

Source:http://linkedlifedata.com/resource/pubmed/id/11555613

Download in:

View as

General Info

PMID
11555613